|
|
||||||||
1 Department of Biomedical Engineering, Northwestern University, Evanston, Illinois 60208; 2 Institute for Environmental Medicine and 3 Department of Anesthesia and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104
| |
ABSTRACT |
|---|
|
|
|---|
Cerebral gas embolism is a serious consequence of diving. It is associated with decompression sickness and is assumed to cause severe neurological dysfunction. A mathematical model previously developed to calculate embolism absorption time based on in vivo bubble geometry is used in which various conditions of hyperbaric therapy are considered. Effects of varying external pressure and inert gas concentrations in the breathing mixtures, according to US Navy and Royal Navy diving treatment tables, are predicted. Recompression alone is calculated to reduce absorption times of a 50-nl bubble by up to 98% over the untreated case. Lowering the inhaled inert gas concentration from 67.5% to 50% reduces absorption time by 37% at a given pressure. Bubbles formed after diving and decompression with He are calculated to absorb up to 73% faster than bubbles created after diving and decompression with air, regardless of the recompression gas breathed. This model is a useful alternative to impractical clinical trials in assessing which initial step in hyperbaric therapy is most effective in eliminating cerebral gas embolisms should they occur.
decompression sickness; diffusion; multiple gas model; in vivo geometry
| |
INTRODUCTION |
|---|
|
|
|---|
MULTIFOCAL CEREBRAL GAS EMBOLISM (CGE) is a known risk of cardiac operations and a recognized hazard of diving decompression (11). Some of the most serious consequences associated with diving fall in the category of type II decompression sickness (DCS) and involve neurological dysfunction such as motor, sensory, or mental impairment, convulsions, coma, and death (Ref. 14; Association of Diving Contractors, unpublished observations). The cause of the neurological changes is considered, at least in part, to be the result of a diver's ascent rate to the surface exceeding his ability to maintain inert gas remaining in the tissues in a dissolved state. The gas may come out of solution via nucleation and grow into multiple bubbles that are disseminated throughout the tissue and vasculature. Some of these intravascular bubbles potentially become entrapped in the arterial cerebral circulation and cause the local transient ischemia responsible for the diver's neurological impairment (11).
Regardless of the cause, the primary treatment modality for CGE is hyperbaric therapy (HT) (11). This treatment consists of initially "recompressing" the patient to an elevated external pressure and usually includes providing a specialized breathing mixture. This breathing mixture can contain one of several gas combinations, air, nitrox (an N2-O2 mixture), or heliox (an He-O2 mixture), as well as a variable percentage of inert gas (79, 67.5, or 50%), with O2 providing the balance. The ambient pressure and breathing mixtures are subsequently changed over time in a stepwise fashion to return the patient to atmospheric pressure and air breathing with minimal trauma.
The HT protocol depends on the symptoms presented, the depth and length of the dive, and available facilities; however, experiments to define the limits of recompression and variable O2 treatment are not carried out in humans suffering from DCS. Protocols have been established based on large numbers of clinical experiences with individual cases in naval and industrial organizations. A mathematical model defining the impact of increased levels of external pressure and inhaled O2 content would, therefore, be very useful in understanding and elucidating potentially beneficial treatment combinations.
Some of the most recognized mathematical models used for calculating bubble growth or decay have assumed a spherical bubble geometry, even when intravascular gas bubbles are simulated (6, 8). On the basis of our earlier published observations (3) and those of other investigators (7, 13), however, it has been shown that gas emboli do not maintain a spherical shape when entrapped in the vessels. The bubbles initially fill the vessel diameter and elongate axially, taking on a "sausage-like" appearance. Using this information, we previously developed a generalized mathematical model calculating the absorption times of single bubbles trapped inside the vasculature that is based on their initial in vivo geometry. This model was validated through microvascular experiments under ambient conditions and predicted actual absorption times in the intact rat cremaster circulation more accurately than the models in which a spherical configuration was assumed (3).
The goal of this study is to apply our earlier model, by use of a realistic intravascular bubble geometry, to the situation of hyperbaria. This work is a natural extension of our earlier methods and provides the opportunity to manipulate parameters such as external pressure and breathing gas to examine their effects on intravascular bubble absorption dynamics. The importance of this work lies in the fact that this is the first attempt to describe how hyperbaria changes the normal absorption process of CBEs as they appear in vivo.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Model.
The theoretical model we developed to calculate absorption times of a
CGE has been described in detail previously (3) but is
mentioned very briefly below. We have modeled the in vivo shape of a
cerebrovascular bubble as a cylinder of initial length
Lo, with hemispherical end caps of initial
radius Ro (Fig.
1). On the basis of in vivo findings, we
stipulate that, as gas absorbs out of the bubble, the cylindrical
portion of the embolism decreases in length while the radius of the
hemispherical end caps remains fixed. Once the cylindrical portion
completely disappears, the remaining hemispherical end caps fuse
together to form a sphere. This spherical geometry is maintained for
the remainder of the bubble absorption. The absorption of the bubble
can, therefore, be solved independently for two separate phases in
time, the cylindrical phase and the spherical phase, in each case with
the use of Fick's law for the specific bubble geometry. The time for
the bubble to absorb is highly dependent on the initial aspect ratio of
the bubble itself, or
Lo/Ro.
|
Multigas model. The situation in which a diver is breathing one gas mixture during a dive and decompression and another gas mixture during HT becomes more complicated. A CGE that forms during or after the diver surfaces is composed of the inert gas inhaled during the dive and decompression, inasmuch as this is the gas present in the tissues at the time of bubble nucleation and growth. This gas inside the bubble will follow its concentration gradient, diffusing out of the bubble after the diver surfaces. Introducing a second inert gas in the inhaled breathing mixture during recompression loads the tissues and arterial blood with a new gas species heretofore not present inside the bubble. While the gas inside the bubble diffuses outward, the new gas present in the tissues follows its concentration gradient, diffusing into the bubble. The net effect of gases moving into and out of the bubble can be to slow absorption or even promote bubble growth. To describe this more complex situation, we developed the in vivo multiple gas model based on the same bubble geometry as described above and the basic assumptions defined by Burkard and Van Liew (4).
Our multiple gas model was validated by simulating conditions of only one gas and comparing results with those obtained from the single gas model for a given bubble volume and geometry. In all cases, the absorption times calculated using any of the models never differed by >2.0%.Simulations. We examined three groups of DCS treatments: hyperbaric simulations with air, hyperbaric simulations with variable O2, and multigas simulations. The simulations were applied to the specific case of a cerebrovascular bubble, since arterial emboli in the cerebral circulation are assumed to be responsible for the most serious consequences associated with DCS (11). A single representative bubble was used for simplicity, albeit DCS is usually characterized by multiple gas emboli distributed throughout the vasculature and tissues. A bubble, initially 50 nl in volume at ambient pressure, was simulated, because this embolism size is a reasonable estimate based on physiological bubbles seen by Powell and Weydig (13) in the microcirculation of adipose tissue of rats and rabbits exposed to rapid decompression.
We assumed that all divers maintained a constant body temperature of 37°C during treatment. The appropriate physiological parameters for cerebral tissue were found in the literature (4, 6, 18) or estimated on the basis of available information and are presented in Table 1.
|
Hyperbaric simulations with air. We compared the absorption time of a 50-nl bubble left untreated at an external pressure of 1 atmosphere absolute (ATA) with a bubble of the same volume recompressed to pressures of 2.8, 4, and 6 ATA. We selected these values of hyperbaric pressure for our simulations, because the Association of Diving Contractors recommends recompression to 2.8 ATA or 60 feet of seawater (fsw) (Association of Diving Contractors, unpublished observations) for simple DCS symptoms such as limb pain or skin rash, without any accompanying neurological deficit. If, however, there are any signs of type II DCS, the US Navy Diving Treatment Table 6A (16) prescribes an immediate compression to 6 ATA or 165 fsw. To demonstrate the theoretical effects of an intermediate external pressure, we selected 4 ATA, a pressure shown by Waite et al. (19) to be sufficient to cause the disappearance of all cerebrovascular emboli in physiological experiments with dogs breathing air. All simulations used 79% N2-21% O2 as the breathing mixture during therapy.
Hyperbaric simulations with variable O2. To demonstrate the efficacy of accelerating bubble absorption with use of increased concentrations of O2 in the breathing mixtures during HT, we compared the absorption times of a 50-nl bubble on the surface recompressed to 2.8, 4, and 6 ATA in a patient breathing 21% O2-79% N2 (air), 32.5% O2-67.5% N2, and 50% O2-50% N2. All three of these breathing mixtures are used clinically to treat DCS, depending on the situation presented. The US Navy and Royal Navy Diving Manuals define a treatment for type II DCS that begins with an initial recompression to 6 ATA; however, the US Navy generally supports using 79% N2-21% O2 as the breathing gas, whereas the Royal Navy recommends 67.5% N2-32.5% O2 (11, 16). A 50% O2-50% N2 breathing mixture is endorsed by the Association of Diving Contractors during the initial step of recompression to 6 ATA, but only in cases when a diver with serious DCS has surfaced from an air dive shallower than 6 ATA (unpublished observations).
Multigas simulations. The multigas simulations use the multiple gas model to calculate the time rate of change of the bubble volume for a 50-nl CGE at ambient conditions under an applied external pressure of 6 ATA. The recompressed bubble was given a fixed Lo/Ro of 2.6, inasmuch as this bubble configuration was shown to give the longest absorption times (i.e., representative of the worst-case scenario) at a given bubble volume (3). Heliox, an He-O2 mixture, is a breathing gas used primarily by commercial and military divers (2); therefore, the multigas simulations were run using heliox (21% O2-79% He) and air (21% O2-79% N2). The model was used to simulate events for the four possible combinations stemming from use of these two inert gases during the two phases of the diving and decompression-recompression: N2O2-N2O2, HeO2-HeO2, N2O2-HeO2, and HeO2-N2O2.
In all the hyperbaric therapies simulated, regardless of the breathing mixture, we predicted that the total time a recompressed 50-nl bubble would take to absorb was
30 min. The US Navy and Royal Navy
recompression protocols require that the diver spend
25-30 min
at the initial hyperbaric pressure of 6 ATA; therefore, simulating the
initial step of HT is sufficient to model complete embolism absorption
into the bloodstream.
| |
RESULTS |
|---|
|
|
|---|
The time rate of change of bubble volume during absorption for a
50-nl CBE left untreated in a patient breathing air at ambient pressure
is depicted in Fig. 2 for two
configurations: a spherical bubble
(Lo/Ro = 0) and a
bubble with Lo/Ro of 2.6. These two values for
Lo/Ro were found
to give the minimum and maximum absorption time, respectively, for a
bubble of a given volume (3). The model predicts that a
spherical bubble with an initial radius of 228 µm would take 177 min
to absorb, whereas a bubble of the same volume with an initial radius
of 159 µm and an initial central core length of 414 µm would take
296 min to absorb (Fig. 2). The maximum absorption time for a 50-nl
bubble is, therefore, 67% longer than if the bubble were to remain a
sphere. The discontinuity in the volume vs. time curve for the embolism
with Lo/Ro of 2.6 represents the transition from the cylindrical to the spherical absorption phase, as discussed elsewhere (3).
|
Hyperbaric simulations with air.
We used our model to calculate the theoretical absorption times of an
air bubble, initially 50 nl at sea level, over a range of geometries at
several different hyperbaric pressures. Because embolism absorption
time is clearly dependent on
Lo/Ro and, hence, initial bubble geometry (Fig. 2), we plotted the total time for bubble
absorption as a function of initial surface area, corresponding to
Lo/Ro between 0 (spherical bubbles) and 25 (long slender bubbles). Each recompression
pressure, 2.8, 4, and 6 ATA, generates a unique initial bubble volume;
therefore, each curve in Fig. 3
represents a different initial bubble volume over the same range of
Lo/Ro values.
|
Hyperbaric simulations with variable O2.
The effects of changing the inert gas content in the inspired breathing
mixture are shown in Fig. 4. The range of
absorption times theoretically possible for a gas bubble, originally 50 nl at ambient conditions, is presented as a function of hyperbaric pressure for various concentrations of O2 in the breathing
mixture during recompression: 21% O2-79% N2,
32.5% O2-67.5% N2, and 50% O2-50% N2. Decreasing the N2
content of the inspired gas from 79% to 67.5% was calculated to
reduce the maximum absorption time of a bubble at 2.8 ATA by
40%,
from 30 to 18 min. An even greater reduction in maximum absorption time
was achieved when the breathing mixture contained 50% O2
instead of 21% O2, changing the maximum CGE residence time
from 30 to 11 min, a decrease of 63%. The relative percent reduction
in maximum absorption time between the various breathing gases was
consistent at all the recompression pressures, 2.8, 4, and 6 ATA.
|
1.3 nl) in the recompressed bubble volume exists between the
different breathing gases at the same hyperbaric pressure. This occurs
because the internal bubble pressure is dependent on the partial
pressure of O2 in the tissue, in equilibrium with the
bubble, which is obviously related to the concentration of O2 in the breathing gas.
At specific pressures, the curves representing the maximum and minimum
residence times for a cerebrovascular bubble in a patient breathing
each of the gas mixtures do not overlap with one another at any point
in Fig. 4, regardless of the recompression pressure evaluated. The lack
of overlap indicates that even the longest possible absorption time for
a CGE with 32.5% O2 in the breathing mixture at a given
pressure is still
4% more rapid than the shortest possible
absorption time in a patient breathing 21% O2. Likewise, the same-size CGE in a patient breathing 50% O2 absorbs a
minimum of 5% faster and a maximum of 37% faster than if the patient
were breathing 32.5% O2.
Multigas simulations.
The step change in bubble volume, as a result of the initial
recompression from sea level to 6 ATA, is from 50 nl at ambient pressure to 6.9 nl. The subsequent changes in bubble volume over time
during HT at 6 ATA for four different diving and
decompression-recompression gas variations are shown in Fig.
5. The shortest absorption time predicted
for any of the combinations was 4.4 min, in the case of an
individual breathing He continually during the dive,
decompression, and recompression therapy
(HeO2-HeO2). Changing the recompression breathing mixture to N2 instead of He (the
HeO2-N2O2 case) increased bubble
absorption time by only ~3%. However, although overall absorption
time was slightly longer in the
HeO2-N2O2 than in the HeO2-HeO2 case, bubble absorption was actually
accelerated for a majority of time, as indicated by a smaller bubble
volume at any given time. When the bubble was formed by breathing
N2 during diving and decompression, regardless of the gas
inhaled during recompression, however, absorption times increased
dramatically, by 49% in the
N2O2-HeO2 case and by 73% with
N2O2-N2O2. The multigas combination of a bubble initially composed of N2 and
absorbing in the presence of He was the only case that showed even a
temporary increase in bubble volume, although the absorption time, 6.5 min, was still predicted to be less than in the
N2O2-N2O2 case of 7.6 min.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
In the absence of the ability to assess the most effective treatment options available with HT clinically, a mathematical model was used to predict the residence time of a gas embolism as a function of specific bubble geometry (Fig. 1) and various treatment parameters. An entrapped 50-nl embolism left untreated in the cerebral circulation is predicted to have absorption times of ~177 to 296 ± 2 min depending on the configuration (Fig. 2) and the model used. As shown in Fig. 3, the residence time of a cerebrovascular bubble is a nonlinear function of initial surface area, demonstrating competing mechanisms for bubble absorption. Increasing the bubble surface area, through bubble elongation and narrowing, creates a larger area for gas diffusion out of the bubble and is advantageous for absorption; however, this alone does not lead to a decrease in absorption time. An increased surface area also indicates a longer bubble length and, therefore, a greater fraction of bubble volume, which must be absorbed before the cylindrical core disappears and the internal pressure rises. This theoretically inhibits bubble absorption, especially in aspect ratios between 0.3 and 13.1, and has heretofore been overlooked in theoretical models in which a spherical bubble geometry is assumed (3).
To illustrate the theoretical basis behind the clinically proven therapeutic effects of recompression and various inhaled gas mixtures on embolism absorption dynamics, we simulated the conditions of hyperbaria with air and hyperbaria with variable O2 and multiple gases used to treat patients with DCS with our theoretical model.
Hyperbaric simulations with air. In Fig. 3, a recompression pressure as low as 2.8 ATA is shown to have a dramatic effect on reducing the bubble absorption time, by ~90%. This decrease in the residence time is attributed in part to the large reduction in bubble volume. The large increase in external pressure due to hyperbaria does not change the basic behavior of bubble absorption, however, inasmuch as all the curves presented in Fig. 3 have the same fundamental shape.
Hyperbaric simulations with variable O2. HT can include a manipulation not only of the external pressure but also of the inhaled breathing mixture. The combination of these therapies demonstrates that lowering the inert gas content in the breathing mixture from 79% to 67.5% or 50% at a given recompression pressure is a viable way to decrease bubble absorption time from 40% to 63% for all pressures (Fig. 4). Reducing the inert gas concentration in the inspired gas mixture is shown to increase the rate of bubble absorption to similar values obtained by increasing the external pressure. The drawbacks associated with this manipulation are not included in the model, however. Theoretically, the optimal breathing mixture at any recompression pressure would be 100% O2, thereby reducing to zero the inert gas percentage in the breathing mixture and the tissues and maximally accelerating diffusion out of the bubble. The most significant problem associated with this approach is O2 toxicity, manifested by sudden seizures (5). O2 toxicity is particularly harmful in previously ischemic tissue, injuring endothelial cells (10, 15). Inhalation of 100% O2 has proven to be beneficial in the continuation of therapy; however, when the patient is initially subjected to large recompression pressures and a high O2 content in the breathing mixture, O2 toxicity becomes an obvious concern. The disadvantage of keeping the O2 content at 21% is the extensive time required to return the patient to ambient pressure (Ref. 16; Association of Diving Contractors, unpublished observations).
A difference of 1-28 min can be achieved in absorption times by adjusting the recompression pressure and inhalation mixture, a time potentially vital to the patient's recovery. Any prolongation of bubble absorption is additional time during which cerebral tissue is cut off from blood flow and susceptible to ischemia. The perpetuation of the gas embolism within the vasculature can also cause platelet aggregation, activation of the thromboinflammatory pathways, and damage to the endothelium, all through contact at the gas-blood vessel interface (1, 12, 20). In addition, this model was run only for a representative CGE of 50 nl at ambient pressure. A larger initial bubble volume would also show a larger discrepancy in bubble absorption times. The model demonstrates the two primary factors, which are manipulated during HT to reduce the residence time of CGE: external pressure and inert gas content of the breathing mixture. Within the limits of these parameters, there is room for considerable adjustment of both. Although a difference of 28 min in CGE absorption time may not appear significant when the total time required to diagnose, transport, and prepare the patient is considered, this difference in time represents a discrepancy between various treatment methods, during which the embolism is made to shrink. During the diagnosis and transport stages, the embolism can be growing in size and numbers, inasmuch as divers can experience an exacerbation of symptoms before treatment (Association of Diving Contractors, unpublished observations). For this reason, prompt initiation of therapy is extremely important, and once treatment has begun, everything possible should be done to reduce the residence time of the embolism. This model can be used in assessing the benefits associated with the possible combinations in recompression therapy and can aid in understanding the relationship between the various aspects involved in the clinical treatment of CGE.Multigas simulations. To investigate other bubble absorption phenomena, which occur in divers exposed to more than one breathing gas, we incorporated the multiple gas concept, accounting for divers breathing one inert gas during the dive and decompression and another during the recompression therapy. One might initially predict that combinations with different inhalation gases for diving and recompression will absorb most quickly, inasmuch as the tissue concentration of the gas species inside the bubble during recompression would be negligible, thus increasing the gradient that drives absorption out of the bubble. Although this is basically true, counterdiffusion of the new inert gas, introduced in the breathing mixture, into the bubble during recompression effectively slows absorption. The model presented accounts for this important effect.
The counterdiffusion of gas into the bubble is responsible for the initial increase of bubble volume predicted in the multiple gas case, in which a diver inhaling N2 and O2 during a dive and presenting with CGEs is recompressed while breathing He and O2. This same bubble growth does not occur in a gas embolism of a patient diving with He and being recompressed with N2 (Fig. 5). The results of the simulations also predict that the absorption time of a CGE is actually longest in a diver continually breathing air during the dive, decompression, and recompression, as illustrated in Fig. 5, 61 s longer than if the patient were inhaling He as the inert gas during compression. These results agree with physiological experiments performed by Hyldegaard et al. (9) demonstrating a reduced residence time for bubbles in rats when He was given as the inert breathing mixture instead of N2 after the animals surfaced from decompression with air. The two emboli initially containing He appear to have distinctly faster absorption than the bubbles initially containing N2, regardless of the recompression gas inhaled. This is in part due to the high diffusion coefficient of He, which promotes its rapid efflux (Table 1). To understand the mechanisms behind the bubble absorption dynamics in the multiple gas cases, it becomes necessary to examine total bubble volume as a function of the individual inert gas volumes at any given time (Fig. 6). Of the two initial inert gases in each of the bubbles, He has a much faster rate of absorption into the cerebral tissue than N2. Similarly, He proves to have the larger rate of diffusion into the bubble from the tissues as well. In combination, these factors dictate that the embolism composed of He and collapsing during a recompression with N2 will absorb much faster than if the opposing conditions are present. The clinical implications of this prediction are that an embolism appearing in a patient after surfacing from a He dive would reside for a shorter time in a vessel with less likelihood of causing cerebral ischemic injury than if the embolism were created from an air dive. A difference of ~2 min may not be enough to affect clinical treatment, but it may reflect the relation between tissue ischemia and infarction. The model aids in prediction of absorption dynamics when a diver is exposed to multiple gases during decompression-induced gas embolism and therapy and indicates potential for decreasing the bubble residence time. This model, while helpful in gaining a basic understanding of bubble dynamics in the presence of elevated external pressures and different inhaled gas mixtures, also has limitations. When various aspects of HT are simulated, the manipulations in recompression pressures or breathing gases are modeled as instantaneous step changes to simplify the solution. In reality, it takes ~3-5 min to recompress a patient to 6 ATA, depending on his tolerance, during which time the inert gas in the tissue must also approach equilibrium with the breathing mixture, and this has not been factored into the model. To further simplify the model, we assumed that once a bubble became entrapped in a cerebral vessel at a given initial geometry and hyperbaric pressure, the bubble did not dislodge to a location further downstream with a new aspect ratio, although this has been observed occasionally in vivo (3). This theoretical model is based on the configuration of a CGE in vivo and demonstrates the various interactions of bubble geometry, recompression pressure, and inhaled gas mixtures taking part in determining the residence time. Manipulating the different parameters individually and in conjunction with one another to simulate events resulting from general practice in the initial treatment phase of DCS provides a simple and effective method of establishing the relevant factors in determining the absorption time and basic dynamics of CGEs. Once these factors are well understood, the model can be used to predict the limits of current and experimental therapies to reduce the damaging effects of CGE.| |
ACKNOWLEDGEMENTS |
|---|
Dr. Roderic Eckenhoff provided helpful discussion.
| |
FOOTNOTES |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grant R01 HL-60230.
Address for reprint requests and other correspondence: D. M. Eckmann, Dept. of Anesthesia, University of Pennsylvania, 7 Dulles/HUP, 3,400 Spruce St., Philadelphia, PA 19104 (E-mail: deckmann{at}mail.med.upenn.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 18 February 2000; accepted in final form 1 September 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Albertine, KH,
Wiener-Kronish JP,
Koike K,
and
Staub NC.
Quantification of damage by air emboli to lung microvessels in anesthetized sheep.
J Appl Physiol
57:
1360-1368,
1984
2.
Bennett, PD.
Inert gas narcosis.
In: The Physiology and Medicine of Diving, edited by Bennett PD,
and Elliott DH.. San Pedro, CA: Best, 1982, p. 239-261.
3.
Branger, AB,
and
Eckmann DM.
Theoretical and experimental intravascular gas embolism absorption dynamics.
J Appl Physiol
87:
1287-1295,
1999
4.
Burkard, ME,
and
Van Liew HD.
Simulation of exchanges of multiple gases in bubbles in the body.
Respir Physiol
95:
131-145,
1994[ISI][Medline].
5.
Clark, JJ.
Oxygen toxicity.
In: The Physiology and Medicine of Diving, edited by Bennett PD,
and Elliott DH.. San Pedro, CA: Best, 1982, p. 201-238.
6.
Dexter, F,
and
Hindman BJ.
Recommendations for hyperbaric oxygen therapy of cerebral air embolism based on a mathematical model of bubble absorption.
Anesth Analg
84:
1203-1207,
1997[Abstract].
7.
Feinstein, SB,
Shah PM,
Bing RJ,
Meerbaum S,
Corday E,
Chang B-L,
Santillan G,
and
Fujibayashi Y.
Microbubble dynamics visualized in the intact capillary circulation.
J Am Coll Cardiol
4:
595-600,
1984[Abstract].
8.
Hlastala, MP,
and
Van Liew HD.
Absorption of in vivo inert gas bubbles.
Respir Physiol
24:
147-158,
1975[ISI][Medline].
9.
Hyldegaard, O,
Moller M,
and
Madsen J.
Effect of He-O2, O2, and N2O-O2 breathing on injected bubbles in spinal white matter.
Undersea Biomed Res
18:
361-371,
1991[ISI][Medline].
10.
Kazzaz, JA,
Xu J,
Palaia TA,
Mantell L,
Fein AM,
and
Horowitz S.
Cellular oxygen toxicity: oxidant injury without apoptosis.
J Biol Chem
271:
15182-15186,
1996
11.
McDermott, JJ,
Dutka AJ,
Koller WA,
and
Flynn ET.
Effects of an increased PO2 during recompression therapy for the treatment of experimental cerebral arterial gas embolism.
Undersea Biomed Res
19:
403-413,
1992[ISI][Medline].
12.
Philp, RB,
Inwood MJ,
and
Warren BA.
Interactions between gas bubbles and components of the blood: implications in decompression sickness.
Aerospace Med
43:
946-953,
1972[Medline].
13.
Powell, MR,
and
Weydig KJ.
In Vivo Bubble Growth Studies Following Decompression. Tarrytown, NY: Union Carbide Technical Center, 1974. (Tech Rep CRT-T-798.74)
14.
Reul, J,
Weis J,
Jung A,
Willmes K,
and
Thron A.
Central nervous system lesions and cervical disc herniations in amateur divers.
Lancet
345:
1403-1405,
1995[ISI][Medline].
15.
Shinomiya, N,
Suzuki S,
Hashimoto A,
Ito N,
Takaai Y,
and
Oiwa H.
Effect of hyperbaric oxygen on intracellular adhesion molecule-1 (ICAM-1) expression in murine lung.
Aviat Space Environ Med
69:
1-7,
1998[Medline].
16.
US Navy.
US Navy Diving Manual, revision 4. Washington, DC: GPO, 2000. (Navsea Tech. Manual 5, 21-42).
18.
Van Liew, HD,
Conkin J,
and
Burkard ME.
The oxygen window and decompression bubbles: estimates and significance.
Aviat Space Environ Med
64:
859-865,
1993[Medline].
19.
Waite CL, Mazzone WF, Greenwood ME, and Larsen RT. Dysbaric
cerebral air embolism. Proc 3rd Symp Underwater Physiol
1967, p. 205-215.
20.
Warren, BA,
Philp RB,
and
Inwood MJ.
The ultrastructural morphology of air embolism: platelet adhesion to the interface and endothelial damage.
Br J Exp Pathol
54:
163-172,
1973[ISI][Medline].
This article has been cited by other articles:
![]() |
D. M. ECKMANN, J. ZHANG, J. LAMPE, and P. S. AYYASWAMY Gas embolism and surfactant-based intervention: implications for long-duration space-based activity. Ann. N.Y. Acad. Sci., September 1, 2006; 1077: 256 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.L. Gill and C.N.A. Bell Hyperbaric oxygen: its uses, mechanisms of action and outcomes QJM, July 1, 2004; 97(7): 385 - 395. [Full Text] [PDF] |
||||
![]() |
D. M. Eckmann and V. N. Lomivorotov Microvascular gas embolization clearance following perfluorocarbon administration J Appl Physiol, March 1, 2003; 94(3): 860 - 868. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |